{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T08:53:06Z","timestamp":1784364786216,"version":"3.55.0"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T00:00:00Z","timestamp":1666051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Background and aim<\/jats:title><jats:p>Inflammatory myopathies are heterogeneous in terms of etiology, (immuno)pathology, and clinical findings. Endothelial cell injury, as it occurs in DM, is a common feature of numerous inflammatory and non-inflammatory vascular diseases. Vascular regeneration is mediated by both local and blood-derived mechanisms, such as the mobilization and activation of so-called proangiogenic cells (PACs) or early endothelial progenitor cells (eEPCs). The current study aimed to evaluate parameters of eEPC integrity in dermatomyositis (DM), compared to necrotizing myopathy (NM) and to non-myopathic controls.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Blood samples from DM and NM patients were compared to non-myositis controls and analyzed for the following parameters: circulating CD133<jats:sup>+<\/jats:sup>\/VEGFR-2<jats:sup>+<\/jats:sup> cells, number of colony-forming unit endothelial cells (CFU-ECs), concentrations of angiopoietin 1, vascular endothelial growth factor (VEGF), and CXCL-16. Muscle biopsies from DM and NM subjects underwent immunofluorescence analysis for CXCR6, nestin, and CD31 (PECAM-1). Finally, myotubes, derived from healthy donors, were stimulated with serum samples from DM and NM patients, subsequently followed by RT-PCR for the following candidates: IL-1\u03b2, IL-6, nestin, and CD31.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Seventeen (17) DM patients, 7 NM patients, and 40 non-myositis controls were included. CD133<jats:sup>+<\/jats:sup>\/VEGFR-2<jats:sup>+<\/jats:sup> cells did not differ between the groups. Both DM and NM patients showed lower CFU-ECs than controls. In DM, intramuscular CD31 abundances were significantly reduced, which indicated vascular rarefaction. Muscular CXCR6 was elevated in both diseases. Circulating CXCL-16 was higher in DM and NM in contrast, compared to controls. Serum from patients with DM but not NM induced a profound upregulation of mRNS expression of CD31 and IL-6 in cultured myotubes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our study demonstrates the loss of intramuscular microvessels in DM, accompanied by endothelial activation in DM and NM. Vascular regeneration was impaired in DM and NM. The findings suggest a role for inflammation-associated vascular damage in the pathogenesis of DM.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2022.952699","type":"journal-article","created":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T07:41:52Z","timestamp":1666078912000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Impairment of muscular endothelial cell regeneration in dermatomyositis"],"prefix":"10.3389","volume":"13","author":[{"given":"D.","family":"Lemmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Kummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Lemmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Wrede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Seitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Balcarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Schwarze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. A.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Patschan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Patschan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1365-2990.2010.01153.x","article-title":"Review: an update on inflammatory and autoimmune myopathies","volume":"37","author":"Dalakas","year":"2011","journal-title":"Neuropathol Appl Neurobiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1097\/BOR.0b013e328358bd85","article-title":"Myositis autoantibodies","volume":"24","author":"Casciola-Rosen","year":"2012","journal-title":"Curr Opin Rheumatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/joim.12524","article-title":"Diagnosis and classification of idiopathic inflammatory myopathies","volume":"280","author":"Lundberg","year":"2016","journal-title":"J Intern Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1056\/NEJMra1402225","article-title":"Inflammatory muscle diseases","volume":"372","author":"Dalakas","year":"2015","journal-title":"N Engl J Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.bbadis.2014.05.034","article-title":"Dermatomyositis, polymyositis and immune-mediated necrotising myopathies","volume":"1852","author":"Luo","year":"2015","journal-title":"Biochim Biophys Acta."},{"key":"B6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/2324709617709031","article-title":"Necrotizing autoimmune myopathy: a rare variant of idiopathic inflammatory myopathies","author":"Khan","year":"2017","journal-title":"J Investig Med High Impact Case Rep."},{"key":"B7","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1056\/NEJMra020528","article-title":"Thrombotic microangiopathies","volume":"347","author":"Moake","year":"2002","journal-title":"N Engl J Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"R94","DOI":"10.1186\/cc10100","article-title":"Endothelial progenitor cells (EPC) in sepsis with acute renal dysfunction (ARD)","volume":"15","author":"Patschan","year":"2011","journal-title":"Crit Care Lond Engl."},{"key":"B9","doi-asserted-by":"publisher","first-page":"715049","DOI":"10.1155\/2012\/715049","article-title":"Impairment and differential expression of PR3 and MPO on peripheral myelomonocytic cells with endothelial properties in granulomatosis with polyangiitis","volume":"2012","author":"Patschan","year":"2012","journal-title":"Int J Nephrol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.5301\/jn.5000273","article-title":"Endothelial progenitor cells in systemic lupus erythematosus","volume":"26","author":"Patschan","year":"2013","journal-title":"J Nephrol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1126\/science.275.5302.964","article-title":"Isolation of putative progenitor endothelial cells for angiogenesis","volume":"275","author":"Asahara","year":"1997","journal-title":"Science."},{"key":"B12","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCRESAHA.111.243386","article-title":"Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use","volume":"110","author":"Fadini","year":"2012","journal-title":"Circ Res."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00232.2016","article-title":"Postischemic microvasculopathy and endothelial progenitor Cell-based therapy in ischemic AKI - update and perspectives","author":"Patschan","year":"2016","journal-title":"Am J Physiol Renal Physiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e12914","DOI":"10.1111\/apha.12914","article-title":"Endothelial colony-forming cells and pro-angiogenic cells: clarifying definitions and their potential role in mitigating acute kidney injury","volume":"222","author":"Basile","year":"2017","journal-title":"Acta Physiol Oxf Engl."},{"key":"B15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/MOT.0b013e32833454b5","article-title":"Critser MCY. Endothelial colony forming cell role in neoangiogenesis and tissue repair","volume":"15","author":"Paul","year":"2010","journal-title":"Curr Opin Organ Transplant."},{"key":"B16","doi-asserted-by":"publisher","first-page":"H525","DOI":"10.1152\/ajpheart.00058.2004","article-title":"Myocardial neovascularization by bone marrow angioblasts results in cardiomyocyte regeneration","volume":"287","author":"Schuster","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/ana.21919","article-title":"Endothelial progenitor cell transplantation improves long-term stroke outcome in mice","volume":"67","author":"Fan","year":"2010","journal-title":"Ann Neurol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.2174\/138161212802002733","article-title":"Cell therapy for stroke: emphasis on optimizing safety and efficacy profile of endothelial progenitor cells","volume":"18","author":"Kaneko","year":"2012","journal-title":"Curr Pharm Des."},{"key":"B19","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/brb3.175","article-title":"Endothelial progenitor cells in acute ischemic stroke","volume":"3","author":"Mart\u00ed-F\u00e0bregas","year":"2013","journal-title":"Brain Behav."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1161\/01.CIR.0000130639.97284.EC","article-title":"Circulating humoral factors and endothelial progenitor cells in patients with differing coronary collateral support","volume":"109","author":"Lambiase","year":"2004","journal-title":"Circulation."},{"key":"B21","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/j.1523-1755.2004.00784.x","article-title":"Uremia causes endothelial progenitor cell deficiency","volume":"66","author":"de Groot","year":"2004","journal-title":"Kidney Int."},{"key":"B22","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3109\/03009742.2014.926985","article-title":"Tocilizumab increases EPC regeneration in rheumatoid arthritis","volume":"43","author":"Patschan","year":"2014","journal-title":"Scand J Rheumatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4062\/biomolther.2013.113","article-title":"Signals in health and disease","volume":"22","author":"Shibuya","year":"2014","journal-title":"Biomol Ther."},{"key":"B24","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/s13075-017-1481-z","article-title":"Angiogenesis and VEGF-expressing cells are identified predominantly in the fascia rather than in the muscle during the early phase of dermatomyositis","volume":"19","author":"Yoshida","year":"2017","journal-title":"Arthritis Res Ther."},{"key":"B25","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/79738","article-title":"transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo","volume":"1","author":"Matloubian","year":"2000","journal-title":"Nat Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.3892\/or.2015.4520","article-title":"CXCL16 induces angiogenesis in autocrine signaling pathway involving hypoxia-inducible factor 1A in human umbilical vein endothelial cells","volume":"35","author":"Yu","year":"2015","journal-title":"Oncol Rep."},{"key":"B27","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.canlet.2012.08.018","article-title":"Angiopoietins in angiogenesis","volume":"328","author":"Fagiani","year":"2013","journal-title":"Cancer Lett."},{"key":"B28","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3389\/fphys.2015.00161","article-title":"Muscle cell derived angiopoietin-1 contributes to both myogenesis and angiogenesis in the ischemic environment","volume":"6","author":"McClung","year":"2015","journal-title":"Front Physiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1136\/bjsm.18.3.157","article-title":"Janda \u201cMuscle Function Testing\u201d","volume":"18","author":"Watkins","year":"1984","journal-title":"Br J Sports Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/jca.20208","article-title":"lipid apheresis rapidly increases peripheral endothelial progenitor cell competence","volume":"24","author":"Patschan","year":"2009","journal-title":"J Clin Apheresis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/sj.ki.5002102","article-title":"Normal distribution and medullary-to-cortical shift of Nestin-expressing cells in acute renal ischemia","volume":"71","author":"Patschan","year":"2007","journal-title":"Kidney Int."},{"key":"B32","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1089\/scd.2004.13.658","article-title":"Nestin expression by newly formed human blood vessels","volume":"13","author":"Mokr\u00fd","year":"2004","journal-title":"Stem Cells Dev."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1242\/jcs.106.4.1291","article-title":"Transient expression of the intermediate filament nestin during skeletal muscle development","volume":"106","author":"Sejersen","year":"1993","journal-title":"J Cell Sci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.yjmcc.2010.07.009","article-title":"Endothelial progenitor cells: quo vadis?","volume":"50","author":"Richardson","year":"2011","journal-title":"J Mol Cell Cardiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1093\/rheumatology\/kew288","article-title":"Dysfunction of endothelial progenitor cells is associated with the type I IFN pathway in patients with polymyositis and dermatomyositis","volume":"55","author":"Ekholm","year":"2016","journal-title":"Rheumatol Oxf Engl."},{"key":"B36","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s11926-010-0101-6","article-title":"Dermatomyositis and type 1 interferons","volume":"12","author":"Greenberg","year":"2010","journal-title":"Curr Rheumatol Rep."},{"key":"B37","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/BOR.0000000000000088","article-title":"The Inflammasome and lupus- another innate immune mechanism contributing to disease pathogenesis?","volume":"26","author":"Kahlenberg","year":"2014","journal-title":"Curr Opin Rheumatol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"4457","DOI":"10.4049\/jimmunol.1001782","article-title":"The detrimental effects of IFN-alpha on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction","volume":"185","author":"Thacker","year":"2010","journal-title":"J Immunol Baltim Md."},{"key":"B39","doi-asserted-by":"publisher","first-page":"6143","DOI":"10.4049\/jimmunol.1101284","article-title":"Inflammasome activation of IL-18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus","volume":"187","author":"Kahlenberg","year":"2011","journal-title":"J Immunol Baltim Md."},{"key":"B40","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3389\/fneur.2016.00064","article-title":"Idiopathic inflammatory myopathies: clinical approach and management","volume":"7","author":"Malik","year":"2016","journal-title":"Front Neurol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1001\/jama.2010.1977","article-title":"Deciphering the clinical presentations, pathogenesis, and treatment of the idiopathic inflammatory myopathies","volume":"305","author":"Rider","year":"2011","journal-title":"JAMA."},{"key":"B42","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1136\/annrheumdis-2012-201822","article-title":"Whole microvascular unit deletions in dermatomyositis","volume":"72","author":"Gitiaux","year":"2013","journal-title":"Ann Rheum Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.nmd.2012.09.001","article-title":"Pipestem capillaries in necrotizing myopathy revisited","volume":"23","author":"Schr\u00f6der","year":"2013","journal-title":"Neuromuscul Disord NMD."},{"key":"B44","doi-asserted-by":"publisher","first-page":"665","DOI":"10.14670\/HH-20.665","article-title":"Nestin structure and predicted function in cellular cytoskeletal organization","volume":"20","author":"Michalczyk","year":"2005","journal-title":"Histol Histopathol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1369\/jhc.2010.955609","article-title":"The neural stem\/progenitor cell marker nestin is expressed in proliferative endothelial cells, but not in mature vasculature","volume":"58","author":"Suzuki","year":"2010","journal-title":"J Histochem Cytochem Off J Histochem Soc."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1002\/art.37981","article-title":"Evidence that CXCL16 is a potent mediator of angiogenesis and is involved in endothelial progenitor cell chemotaxis : studies in mice with K\/BxN serum-induced arthritis","volume":"65","author":"Isozaki","year":"2013","journal-title":"Arthritis Rheum."},{"key":"B47","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.mcn.2008.03.009","article-title":"The chemokine CXCL16 induces migration and invasion of glial precursor cells via its receptor CXCR6","volume":"39","author":"Hattermann","year":"2008","journal-title":"Mol Cell Neurosci."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.5551\/jat.29942","article-title":"CXCL16 in Vascular pathology research: from macro effects to microRNAs","volume":"22","author":"Jovanovi\u0107","year":"2015","journal-title":"J Atheroscler Thromb."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.3899\/jrheum.090108","article-title":"Serum CXCL16 concentrations correlate with the extent of skin sclerosis in patients with systemic sclerosis","volume":"36","author":"Yanaba","year":"2009","journal-title":"J Rheumatol."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.952699\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T07:41:54Z","timestamp":1666078914000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.952699\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,18]]},"references-count":49,"alternative-id":["10.3389\/fneur.2022.952699"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.952699","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,18]]},"article-number":"952699"}}